High concentration antibody and protein formulations
US10034940B2 · kind B2 · utility
14Cited by
42References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 16, 2015 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Aug 23, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to highly concentrated antibody and protein formulations with reduced viscosity that are stable, relatively isotonic and are of low turbidity. The formulations are particularly suitable for subcutaneous administration. The application further describes articles of manufacture containing such formulations and method for using them to treat disorders treatable by the formulated antibody or protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.